2021
DOI: 10.1186/s12866-021-02367-z
|View full text |Cite
|
Sign up to set email alerts
|

Bacteriological profile, antibiotic susceptibility and factors associated with neonatal Septicaemia at Kilembe mines hospital, Kasese District Western Uganda

Abstract: Introduction Neonatal septicaemia is one of the most common leading causes of neonatal morbidity and mortality in developing countries. It is estimated to affect more than 30 million people worldwide annually, potentially leading to 6 million deaths. Objective(s) To determine the prevalence, bacteriological profile, antibiotic susceptibility and factors associated with neonatal septicaemia among neonates suspected to sepsis at Kilembe mines hospita… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
4
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
2

Relationship

1
6

Authors

Journals

citations
Cited by 11 publications
(6 citation statements)
references
References 53 publications
1
4
1
Order By: Relevance
“…Gentamicin is less expensive and often the drug of choice, exposing it to frequent use and subsequent development of resistance by some of these enteric Gram-negative bacteria. The complete susceptibility of all the isolated bacteria to amikacin for which its usage in the empirical treatment of sepsis in neonates is strongly recommended is congruent with earlier findings by Jyothi et al 7 and Zamarano et al 36 Daily single-dose PK-PD parameters of administered amikacin at 15 mg/kg in neonates point to the drug’s efficacy and safety at minimum inhibition corresponding to what was tested in this study. 37 , 38 However, Smits et al 39 suggested the consideration of neonatal covariates of current weight, postnatal age, and perinatal asphyxia in dosing of the drug.…”
Section: Discussionsupporting
confidence: 90%
“…Gentamicin is less expensive and often the drug of choice, exposing it to frequent use and subsequent development of resistance by some of these enteric Gram-negative bacteria. The complete susceptibility of all the isolated bacteria to amikacin for which its usage in the empirical treatment of sepsis in neonates is strongly recommended is congruent with earlier findings by Jyothi et al 7 and Zamarano et al 36 Daily single-dose PK-PD parameters of administered amikacin at 15 mg/kg in neonates point to the drug’s efficacy and safety at minimum inhibition corresponding to what was tested in this study. 37 , 38 However, Smits et al 39 suggested the consideration of neonatal covariates of current weight, postnatal age, and perinatal asphyxia in dosing of the drug.…”
Section: Discussionsupporting
confidence: 90%
“…was also less than previous studies in Africa, Zambia 33% (35), in Egypt 40.7% (36) and Uganda 59% (37). Higher results…”
Section: Discussioncontrasting
confidence: 63%
“…The pathogens were identified using standard microbiological procedures. 11 Isolates of K. pneumoniae were characterized.…”
Section: Phenotypic Identificationmentioning
confidence: 99%